InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Myriad settles BRCA litigation following Federal Circuit ruling

Michael Loney, New York

Myriad Genetics has settled litigation with three of the laboratories it accused of infringing patents on two genes associated with breast and ovarian cancer, following a Federal Circuit ruling last month confirming some of its claims were patent ineligible

The molecular diagnostic company has reached settlements with LabCorp, Invitae, and Pathway Genomics. A statement announcing a settlement was also issued by Ambry, but was quickly retracted. The statement was inadvertently sent out, according to PBS. Myriad is reportedly discussing...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null



May / June 2019

From trademarks to trade secrets: in-house tips on brand protection in China

Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies

Most read articles